Visual acuity gradually improved for up to 5 years in patients with amblyopia, including adults, who were treated with ...

The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first ...

With a workforce shortage and increasing patient demands, it is important for clinical practice leaders in primary care to ...

Healio spoke with Raj Chovatiya, MD, PhD, about results from the phase 3 ICONIC-LEAD trial presented at the 2025 Academy of ...

The proper “dosage” of exercise can be one of the most important components in weight management, according to a presenter at ...

Patients with kidney disease may have their own reasons for not putting their faith in the health care system, but physicians ...

The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...

Living-related conjunctival limbal allograft should be first-line therapy for limbal stem cell deficiency, Edward J. Holland, ...

Parents who learned about firearm safety were significantly more likely to ask about the presence of guns in homes their ...

A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a ...

Screening rates for colorectal cancers were doubled, CRC-related mortality cut in half and racial disparities nearly ...